Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anyu Peibo in Major Depressive Disorder
NCT03183505Phase 2Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Jun 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anyu peibo in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Started Jun 2017; status: completed.
02
Drugs
anyu peibo
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03183505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183505.